Labrador Ventures

Larry Kubal co-founded Labrador Ventures in 1989 and serves as Managing Partner alongside Sean Schickedanz (per public record). The firm operates with a lean partnership model where investment decisions are made collaboratively by the senior partners. Their decades of continuity are central to the firm's governance and sourcing approach.

Labrador Ventures is a dedicated seed and early-stage investor, historically providing the first institutional capital to startups. The firm does not operate growth-equity or late-stage vehicles, maintaining its focus on pre-Series A and Series A rounds. This pure-play seed focus distinguishes it from multi-stage venture firms.

Labrador relies on the long-standing Bay Area networks of its partners, who have been investing in the region since the late 1980s. The firm emphasizes direct relationships with founders and co-investors rather than inbound marketing or platform-driven origination. Its longevity in San Francisco's early-stage community provides proprietary access to pre-institutional rounds.

Labrador's most recent confirmed fund vintage closed in the early 2000s, and the firm has maintained a low public profile since then. Publicly available data does not indicate a recent fundraise or new investment pace. The partnership may continue to manage existing portfolio assets rather than actively deploying a current fund.

Historically, Labrador concentrated on enterprise software, internet infrastructure, and digital media. The firm's portfolio includes companies that shaped billing systems (Portal Software) and connected health (Health Hero Network). It did not diversify heavily into hardware, biotech, or cleantech, maintaining clear sector boundaries.

No public record indicates Labrador Ventures operates a philanthropic foundation, real-asset arm, family office entity, or membership-based co-investor club. The firm appears structured solely as a traditional venture partnership with a focus on early-stage technology investments.

As a seed specialist, Labrador historically reserved capital for follow-on investments in portfolio companies progressing to Series A and beyond. However, given the firm's fund vintages, its ability to exercise pro-rata rights or lead later rounds may now be limited to reserve allocations from prior funds rather than active new deployment.